Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 45,400
-1,750 (-3.71%)
At close: Aug 21, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 662.84 billion as of August 21, 2026.
Market Cap
662.84B
Enterprise Value
193.82B
Revenue
293.03B
Ranking
n/a
PE Ratio
7.06
Stock Price
45,400.00
ChartMarket Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 662.84B, a decrease of -62.76%. That is a compound annual growth rate of -67.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 662.84B | -34.11% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| SD Biosensor | 708.15B |
| Lunit | 685.76B |
| Daewoong | 684.78B |
| Komipharm International | 670.61B |